![Antibe Therapeutics Inc. logo](/logos/ATE.TO.webp)
Antibe Therapeutics Inc.
TSX:ATE.TO
Overview | Financials
Company Name | Antibe Therapeutics Inc. |
Symbol | ATE.TO |
Currency | CAD |
Price | 0.295 |
Market Cap | 15,637,773 |
Dividend Yield | 0% |
52-week-range | 0.15 - 1.23 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Daniel Marcel Legault J.D., L.L.B. |
Website | https://www.antibethera.com |
An error occurred while fetching data.
About Antibe Therapeutics Inc.
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD